Erkki Ruoslahti
Molecular Biology · 2000–2013
A researcher in the Science corpus: 11 papers; trusts 2 researchers and is trusted by 12 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 55 citations into it; #3,866 of 17,773 by trust here, #2,484 by citations
- Cancer Research — 10 citations into it
Whom Erkki Ruoslahti trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Erkki Ruoslahti overall
- Rakesh K. Jain
- C. Mas-Moruno
- S. Mcelwain
- Conroy Sun
- D. Hanahan
- Theresa M. Allen
- Pengfei Lu
- F. Rechenmacher
Papers from Erkki Ruoslahti's perspective
Ordered by how strongly the researchers Erkki Ruoslahti trusts endorse each paper. Same corpus, a different order for every researcher.
- The biology of VEGF and its receptors (Nature Medicine)
- High interstitial fluid pressure — an obstacle in cancer therapy (Nature Reviews. Cancer)
- Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping (Nature Biotechnology)
- Long-circulating and target-specific nanoparticles: theory to practice. (Pharmacological Reviews)
- Renal clearance of quantum dots (Nature Biotechnology)
- Noninvasive imaging of quantum dots in mice. (Bioconjugate chemistry)
- Nanoparticles for drug delivery in cancer treatment. (Urologic oncology)
- Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. (Nature Nanotechnology)
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. (Proceedings of the National Academy of Sciences of the United States of America)
- Molecular mechanisms of lymphangiogenesis in health and disease. (Cancer Cell)
Their papers
- Co-administration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs (2010) — 1,045 citations
- Specialization of tumour vasculature (2002) — 718 citations
- Tissue-penetrating delivery of compounds and nanoparticles into tumors (2009) — 1,099 citations
- Nanocrystal targeting in vivo (2002) — 1,392 citations
- Biodegradable luminescent porous silicon nanoparticles for in vivo applications (2009) — 1,761 citations
- Targeting of drugs and nanoparticles to tumors (2010) — 859 citations
- Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium (2013) — 595 citations
- Platelet-derived Growth Factor Receptor β and Vascular Endothelial Growth Factor Receptor 2 Bind to the β3Integrin through Its Extracellular Domain* (2000) — 283 citations
- C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration (2009) — 782 citations
- Nanoparticles that Communicate In Vivo to Amplify Tumour Targeting (2011) — 487 citations
- Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. (2000) — 885 citations